By contrast, we showed that TRAIL administration to mice with diabetic cardiomyopathy had cardioprotective effects, as it reduced cardiac fibrosis and apoptosis, which are generally contributing to cardiac remodeling [36]. The gene discussed is TNFSF10; the disease is diabetic cardiomyopathy.